This is insanity

Summary

Sydney Watson criticizes the growing use of GLP-1 weight-loss drugs for children, arguing that their use is advancing faster than evidence about their long-term effects on developing bodies and brains.

Wegovy and Saxenda are approved for weight management in children aged 12 and older, while some younger children may receive them off-label. Trials are also underway in children as young as six. The video cites childhood obesity rates of roughly one in five children and reports a sharp increase in GLP-1 prescriptions for weight loss among minors since 2019.

Potential Benefits and Concerns

The video presents examples of both potential benefits and concerns:

• A Good Morning America report describes 15-year-old Adam Renteria, whose obesity had affected his health and daily life. After starting Wegovy, his BMI reportedly fell from 36 to 22.8 over two years.
• A Wall Street Journal article discusses nine-year-old twins with a genetic condition that affects their ability to feel full.

Watson acknowledges that severe obesity can have biological and medical causes, and that conventional approaches may not work for every child. However, she questions whether medication is being treated too casually as a shortcut and whether children and families are adequately informed about uncertainties and the possibility of long-term treatment.

She points to an interview with Eddie Moffitt, who regained weight after stopping Ozempic and later chose to restart it, as an example of the difficulty some people may face when discontinuing these drugs.

Social and Cultural Pressures

Watson highlights the influence of social media, peer pressure, celebrities, and advertising. She cites reporting that some teenagers know peers using GLP-1 drugs without a clear medical reason, and describes concerns about young people sharing or experimenting with medication. One reported incident involved a seven-year-old accidentally taking a large portion of her mother’s medication.

Watson argues that these pressures can reinforce narrow body ideals and may lead parents to push treatment on children.

Watson’s Broader View

Watson argues that childhood obesity should be addressed through better food, activity, and parental involvement, while recognizing that food affordability and quality are also serious factors. She warns that prescribing medication without addressing underlying habits and circumstances could leave those causes unchanged. She also compares the limited long-term evidence to earlier controversies over medical interventions for young people.

She ends with some ambivalence: although she is uneasy about treating children with drugs that may require long-term use, she recognizes that obesity itself can harm children and that medication may help some of them.

Presenters and Contributors

• Presenter: Sydney Watson
• People featured or discussed: Adam Renteria and his mother, Robin; Eddie Moffitt; the nine-year-old twins and their family
• News coverage cited: The Wall Street Journal, Good Morning America, Bloomberg, and 60 Minutes Australia